Scholarship and Biography

Dr. Green is an epidemiologist whose research focuses on drug use, opioid use disorder, and drug-related injury. She earned a Master of Science in Epidemiology and Biostatistics from McGill University and a PhD in Epidemiology from Yale University. She helped design the ASI-MV®, a real-time illicit and prescription drug abuse surveillance system developed by Inflexxion, Inc. Prior to joining the Heller School at Brandeis, she served as Deputy Director of the Boston Medical Center Injury Prevention Center, Associate Professor of Emergency Medicine and Community Health Sciences at the Boston University Schools of Medicine and Public Health. She is an Adjunct Associate Professor at the Warren Alpert School of Medicine at Brown University where she co-directs the Center of Biomedical Research Excellence (COBRE) on Opioids and Overdose at Rhode Island Hospital. Dr. Green helped co-found www.prescribetoprevent.org for prescribers and pharmacists and its companion site www.prevent-protect.org for families, patients, and community organizations. She serves as an advisor to the Rhode Island Governor on addiction and overdose, and consults for the Center for Disease Control and Prevention and the High Intensity Drug Trafficking Areas on public health and public safety opportunities. She served on the Board of Scientific Counselors for the CDC's National Center for Injury Prevention and Control and two recent National Academy of Sciences, Engineering, and Medicine's Committees pertaining to opioid pain management, regulatory strategies to address opioids, and medications for opioid use disorder. Her research is supported by the CDC, the National Institute on Drug Abuse, the Agency for Healthcare Research and Quality, the Patient Centered Outcomes Research Institute, the Bloomberg American Health Initiative, and the Department of Justice.

Links

Website and platform to promote excellence in community drug checking
Website cataloging results from our mathematical model of how much naloxone each state needs to save lives.
Prescribe to Prevent is an intervention for community pharmacies to improve opioid safety.

Honors

Leadership Award, R2X team: Responding to Xylazine
PAARI, Police Assisted Addiction & Recovery Initiative, 2/20/25
Most downloaded paper, Substance Abuse Journal for "Opioid use disorder and the COVID 19 pandemic: A call to sustain regulatory easements and further expand access to treatment"
Association for Medical Education and Research in Substance Abuse, 2020

Organizational Affiliations

Professor and Director of the Opioid Policy Research Collaborative, Heller School for Social Policy and Management, Brandeis University

Adjunct Professor, Brown University (United States, Providence)

Centers for Disease Control and Prevention (United States, Atlanta) - CDC

National Center for Injury Prevention and Control (United States, Atlanta) - NCIPC

National Academy of Sciences (United States, Washington) - NAS

Advisor, Office of the Governor (State of Rhode Island)

Past Affiliations

Associate Professor, Boston University School of Medicine (United States, Boston) - BUSM

Deputy Director of the Boston Medical Center Injury Prevention Center, Boston Medical Center (United States, Boston) - BMC

Co-Director, Center of Biomedical Research Excellence on Opioids and Overdose

Co-Founder, Prescribe to Prevent

Board of Scientific Counselors, Centers for Disease Control and Prevention (United States, Atlanta) - CDC

Education

Yale University
Ph.D.
McGill University
M.Sc.
Tufts University
B.A.